期刊文献+

SLE脑损害危险因素的临床初步分析 被引量:4

The preliminary clinical analysis of risk factors for central nervous system involvement in SLE
暂未订购
导出
摘要 为初步探讨发生SLE脑损害(NPLE)的危险因素,对17例NPLE患者及29例无脑损害的SLE(非NPLE)患者进行临床表现及实验室检查结果方面的统计学比较,并分析NPLE与各临床特点之间的相关性。结果显示,NPLE病组发热、血小板减少、抗Sm抗体阳性、脑脊液(CSF)抗核抗体(ANA)阳性、CSF蛋白增加及氯化物减少的发生率显著高于非NPLE组(P<0.05),而盘状红斑发生率则显著低于非NPLE组(P<0.05);发热、血小板减少、抗Sm抗体阳性、CSFANA阳性、CSF蛋白增加及氯化物减少可能是发生NPLE的危险因素,盘状红斑及抗Ro抗体阳性可能是NPLE的保护性因素。 We investigated risk factors, in clinical situations and laboratory examinations, for CNS involvement in SLE in 17 patients (NPLE) compared with 29 control SLE patients without CNS involvement (non NPLE), and analyzed the correlation between NPLE and clinical manifestation. The results showed that in NPLE there are significant increases of fever, thrombocytopenia, positive anti-Sm antibodies, positive antinuclear antibodies(ANA) in cerebrospinal fluid(CSF), the higher proteins and lower chloride in CSF, while significant decrease in discoid rash. Fever, thrombocytopenia, positive anti Sm antibodies, positive ANA in CSF, the high proteins and low chloride in CSF may be risk factors for NPLE, while discoid rash and anti Ro antibodies may be protective factors for NPLE.
出处 《临床皮肤科杂志》 CAS CSCD 北大核心 2002年第7期426-428,共3页 Journal of Clinical Dermatology
关键词 系统性红斑狼疮 脑脊液 危险因素 脑损害 临床表现 lupus erythematosus,systemic central nervous system cerebrospinal fluid risk factors
  • 相关文献

参考文献3

二级参考文献6

  • 1张奉春,董怡,赵玉华,林禾,姜泉,赵杰.系统性红斑狼疮中枢神经系统病变的诊断及治疗[J].北京医学,1994,16(5):277-280. 被引量:23
  • 2施守义 冯树芳 等.80例SLE的精神神经障碍的临床分析[J].中华皮肤科杂志,1987,20:77-80.
  • 3Lin C Y,Nephron,1989年,53卷,303页
  • 4施守义,中华皮肤科杂志,1987年,20卷,77页
  • 5Tan E M,Arthritis Rheum,1982年,25卷,1271页
  • 6张奉春,北京医学,1994年,16卷,277页

共引文献45

同被引文献38

  • 1扶琼,左晓霞,周亚欧,谢艳丽.神经精神狼疮危险因素的临床分析[J].中华风湿病学杂志,2005,9(1):24-27. 被引量:14
  • 2陆威,劳力民,楼波.神经精神性SLE临床特征分析[J].中华皮肤科杂志,2007,40(6):328-330. 被引量:6
  • 3Cervera R, Khamashta MA, Font J, et al. Morbidity and mortality in SLE during a 10-year period: a comparison of early and late manifestations in a cohort of 1000 patients. Medicine (Baltimore),2003, 82: 299-308.
  • 4Ainiala H, Loukkola J, Peltola J, et al. The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology, 2001, 57: 496-500.
  • 5Carreno L, Lopez-Longo FJ, Monteagudo I, et al. Immunological and clinical differences between juvenile and adult onset of systemic lupus erythematosus. Lupus, 1999, 8: 287-292.
  • 6Font J, Cervera R, Ramos-Casals M, et al. Clusters of clinical and immunologic features in systemic lupus erythematosus:analysis of 600 patients from a single center. Semin Arthritis Rheum,2004, 33: 217-230.
  • 7Karassa FB, Ioannidis JP, Touloumi G, et al. Risk factors for central nervous system involvement in systemic lupus erythematosus. Q J Med, 2000, 93: 169-174.
  • 8Tomita M, Khan RL, Blehm BH, et al. The potenOal pathogenetic link between peripheral immune activation and the central innate immune response in neuropsychiatric systemic lupus erythematosus. Med Hypotheses, 2004, 62: 325-335.
  • 9Janwityanuchit S, Verasertniyom O, Vanichapuntu M, et al. Anti-Sm:its predictive value in systemic lupus erythematosus. Clin Rheumatol, 1993, 12: 350-353.
  • 10Reichlin M. Ribosomal P antibodies and CNS lupus. Lupus,2003, 12: 916-918.

引证文献4

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部